# An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

> **NCT02910739** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 16 (actual)

## Conditions studied

- Amnestic Mild Cognitive Impairment
- Alzheimer's Disease
- Prodromal Alzheimer's Disease

## Interventions

- **DRUG:** MK-8931

## Key facts

- **NCT ID:** NCT02910739
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-11
- **Primary completion:** 2017-04-03
- **Final completion:** 2017-04-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02910739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02910739, "An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT02910739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*